Bomi Italia : 30-05-2017 BOMI ITALIA S.P.A. - BOMI GROUP ANNOUNCES THE ACQUISITION OF THE REMAINING 20% OF G. CARRAI & C. SRL

Bomi Italia S.p.A.

- PRESS RELEASE -

Bomi Group announces the acquisition of the remaining 20% of G.Carrai&C. S.r.l.

Vaprio d'Adda, 30 May 2017 - Bomi Italia S.p.A. ("Bomi" or the "Company" or "Issuer"), the parent company of Gruppo Bomi Group, a market leader in the biomedical logistics sector and the management of high technology healthcare products, which is listed on the multilateral trading system of AIM Italia / Alternative Capital Market announces that it has today finalised the acquisition of the remaining 20% of the share capital of "G.Carrai & C. S.r.l.", a company which operates in the distribution of biomedical products, with a particular focus on residential deliveries, now owned 100% by Bomi.

The transaction, which is consistent with the Bomi Group's strategy of consolidation of minority interests, was carried out following the execution of a call option in accordance with the terms and conditions of the contract signed on 21 May 2015 for a total consideration of Euro 355,500, partly settled in cash and partly through the transfer of the Company's own shares of Euro3.20 each.

Marco Ruini - Vice President and Managing Director of Bomi Italia S.p.A. - commenting on the transaction, stated: "The Group has today made a further small step forward in its strategy of growth and integration of minority interests, in the completion of a succesful acquisition made in 2015, which has contributed to the strengthening of Bomi Group's position in Italy and in the medical equipment and pharmaceuticals transport, warehouse and logistics sector."

Bomi Italia S.p.A., is the Parent Company of Bomi Group, and in the management of high technology healthcare products. It was one of the first companies to receive the "Elite" certificate issued by Borsa Italiana.

Bomi Group's activities are concentrated in the integrated logistics sector and offer a wide range of logistics services in outsourcing to companies operating in the healthcare sector, managing distribution of medical equipment, pharmaceuticals, in-vitro diagnostic equipment, reagents and implant products.

Bomi Group's portfolio of about 100 clients includes some of the world's top healthcare companies (such as the leading pharmaceutical companies and producers of medical devices) as well as small and medium sized companies operating at a global level in the biomedical, diagnostics and biotech industries. Bomi Group currently has about 1,000 employees and operates through subsidiary companies and associated companies in Europe, South America and the United States and its services are also provided, through strategic alliances with local partners.

ISIN Ordinary Share Code: IT0005108748 - Ordinary Share Ticker: BOMI

ISIN Convertible Bond Code: IT00051114480 - Convertible Bond Ticker: BOMI20

For further information.

Bomi Italia S.p.A. ●	Banca Popolare di Vicenza S.p.A. ●
Investor Relations	Nominated Adviser
tel: [phone]	tel: : [phone]
e.mail: [e-mail]	e.mail: [e-mail]